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Lasso peptides are a large family of natural products
that owe their name to a unique structure formed by a
side chain to backbone macrocyclization, resem-
bling a knotted lasso. The unique structure has
significant impact on their biological and physical
properties, as lasso peptides are usually more stable
than linear ones. Current work examines stability,
structure, and biosynthesis of recently discovered
lasso peptide astexin-1, a heat-sensitive lasso pep-
tide. The obtained results revealed a new lasso struc-
ture with a tight loop and long tail as well as narrow
specificity of the maturation machinery for some
essential residues associated with the protease pro-
cessing site, involved in macrolactam ring formation
and entrapment of the tail. Using the astexin-1 struc-
ture, it was possible to rationally construct a thermo-
stable variant of this lasso peptide.
INTRODUCTION
Ribosomally assembled natural products often compensate for
the lack of diversity in building blocks, compared to NRPS- or
PKS-derived molecules, with intensive posttranslational modifi-
cations ranging from acylation over thiazolation/oxazolation to
macrocyclization (Arnison et al., 2013). These modifications
modulate their bioactivity and stabilize them against degrada-
tion. Lasso peptides are quite an exception in this regard,
because their only enzymatically catalyzed posttranslational
modification is a side chain to backbone macrocyclization, re-
sulting in a special three-dimensional (3D) structure that resem-
bles a knotted lasso. This unusual fold stabilizes them against
heat, chemical denaturation, and proteolytic degradation. The
macrolactam ring is formed between the N terminus of a glycine
or cysteine at the first position of the core peptide and the acidic
side chain of an aspartate or glutamate residue at position 8 or 9.
Besides these two highly conserved residues, the primary
sequence is in general variable. In the C-terminal tail sequence,
usually one or two residues with bulky side chains are present
that sterically entrap the tail inside the ring and prevent unfolding
(Duquesne et al., 2007).
The known lasso peptides are divided into three groups ac-
cording to the absence or presence of conserved cysteine resi-
dues. Class I lasso peptides contain four cysteine residues,558 Chemistry & Biology 20, 558–569, April 18, 2013 ª2013 Elsevierincluding position 1, that form two disulfide bonds; class II lasso
peptides lack cysteine residues; and class III, with its only repre-
sentative being BI-32169 (Knappe et al., 2010; Nar et al., 2010),
features two cysteine residues forming one disulfide bond,
whereas position 1 is a glycine as in class II (Xie and Marahiel,
2012).
In addition to their peculiar structure, lasso peptides possess
some interesting bioactivities ranging from antiviral activity
against HIV (Fre´chet et al., 1994; Lin et al., 1996), inhibition of
the glucagon receptor (Potterat et al., 2004), the endothelin
type B receptor (Katahira et al., 1995; Yano et al., 1995), and
the atrial natriuretic factor (Weber et al., 1991; Wyss et al.,
1991) to antimicrobial activities (Iwatsuki et al., 2007; Kimura
et al., 1997; Yano et al., 1996). Becausee most of these effects
were found in focused systematic screens, they may merely be
coincidental, whereas the antibacterial activities may likely
resemble their native function. For the best-studied lasso pep-
tide, microcin J25, and the genome-mining-derived capistruin,
the target has been identified to be the bacterial RNA polymer-
ase (Adelman et al., 2004; Kuznedelov et al., 2011).
Although as few as five lasso peptide biosynthetic gene clus-
ters are known so far, their organization is quite simple as they
only consist of three to five different genes. For the prototypical
lasso peptide microcin J25, the gene organization is as follows.
ThemcjA gene encodes the 58 residue lasso precursor peptide,
which is matured in two steps by the transglutaminase core
domain-containing protein McjB that is assumed to cleave off
the 37 residue leader peptide and the ATP-dependent aspara-
gine synthetase homolog McjC, which is believed to be involved
in the macro cyclization by activation of the acidic side chain.
These catalytic steps were recently shown in vitro, and therefore
the formerly proposed functions of the gene products could be
verified (Pan et al., 2012a; Yan et al., 2012). Furthermore, the
transglutaminase homolog McjB, which contains a catalytic
triad consisting of cysteine, histidine, and aspartate and there-
fore acts as a cysteine protease, is also believed to be associ-
ated with peptide prefolding, because ATP consumption was
essential for catalysis. The maturated lasso peptide is then ex-
ported by McjD, an ATP-binding cassette transporter protein.
In contrast to the four gene clusters of microcin J25 and capi-
struin, the recently discovered lariatin biosynthetic gene cluster
features an additional gene larC. This gene is located upstream
of the gene larD, which encodes a putative protease. It shows
homology to the coenzyme pqq synthesis protein D and was
shown to be essential for lariatin production (Inokoshi et al.,
2012). The most recently discovered lasso peptides cauloseg-
nins I –III originate from a single cluster featuring threeLtd All rights reserved
Figure 1. Expression of the Astexin-1 Biosynthetic Gene Cluster
(A) Schematic representations of the two lasso peptide gene clusters of Asticcacaulis excentricus: the 244x cluster featuring two potential lasso products
astexin-2 and astexin-3 and the astexin-1 gene cluster (222x/atxABC). Full sequence of the astexin-1 precursor peptide and the two main astexin-1 products:
astexin-1(19) and astexin-1(23).
(B) HPLC-MS analysis of the cell pellet of an E. coli strain transformed with Astex_222xABC_pET41 shown as total ion current (TIC) in black; extracted ion
chromatograms (EIC) and UV signal shown in gray. Extracted masses fit to astexin-1(23) red, (22) green, (21) blue, (20) ocher, (19) purple, and (18) teal. Additional
information regarding the purification of heterologously produced astexin-1 is shown in Figure S1.
See also Table S5.
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et al., 2013).
Numerous putative lasso peptide biosynthetic gene clusters
were recently identified in a precursor-driven genome mining
approach (Maksimov et al., 2012). Besides the basic constric-
tions for a lasso peptide precursor (glycine at position 1, gluta-
mate, or aspartate at positions 6 to 10), conserved motifs in
the two processing enzymes B and C were defined and used
for identification of promising clusters. The biosynthetic gene
cluster responsible for the production of astexin-1 was chosen
for further investigation, and the structure of the full-length
astexin-1(23) was obtained.
In this paper, we present a thorough study on two of the main
products of the astexin-1 biosynthetic gene cluster, astexin-
1(19) and astexin-1(23), including biosynthesis, mutagenesis,
thermal stability, and proteolytic stability of the two main astex-
ins and variants generated by mutagenesis. The results we ob-
tained were inconsistent with the recently published structure
(Maksimov et al., 2012). To clarify this apparent contradiction,Chemistry & Biology 20,we reinvestigated the 3D nuclear magnetic resonance (NMR)
structure of astexin-1(19) in aqueous solution. The NMR spectro-
scopic investigation revealed a structure for this lasso peptide
that is in accordance with all results of the stability and muta-
tional analysis.
RESULTS AND DISCUSSION
The Astexin Biosynthesis Cluster
Using a general genome mining approach established by our
group, we were able to identify two putative lasso peptide
biosynthetic gene clusters in the alphaproteobacterium Asticca-
caulis excentricus CB48 (accession no. NC_014816.1 and
NC_014817.1). These clusterswere also discovered in the recent
publication by Maksimov et al. (2012). One cluster features a
single precursor, whereas the other contains two putative pre-
cursors. Remarkably, no ABC transporter was found in a vicinity
of 10 kb of either cluster, while both clusters contain a GntR-
type regulator upstream of the precursor gene (Figure 1A).558–569, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 559
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both clusters featuring genes encoding a putative peptidase as
well as a TonB-dependent receptor. Both clusters were exam-
ined for lasso peptide production in fermentations.
Fermentation of A. excentricus
In the recent publication covering the discovery of astexin-1, no
production of the putative lasso peptide was detectable when
A. excentricus was grown in peptone yeast extract (PYE)
medium (Maksimov et al., 2012). In this study, a more extensive
analysis for homologous production was performed for which
A. excentricus was fermented in PYE, peptone yeast extract
glucose riboflavin, lysogeny broth, M9, M20, and M63 mediums
at 30C. Whereas no growth was observed in M20 and M63,
pellets and supernatants of the other media were extracted
with methanol in accordance with the protocol stated in the
Experimental Procedures. The extracts were evaporated,
resuspended in 50% methanol, and subsequently analyzed via
high-performance liquid chromatography (HPLC) coupled with
high-resolution Fourier transformation mass spectrometry (FT-
MS) (in total abbreviated HPLC-MS). The resulting spectra
were screened for the predicted masses of truncated (D1 to
D7) and full-length products of the single precursor cluster
222x (23 residues) and of the two precursor cluster 244x (24
residues). In the pellet and supernatant extracts of M9 medium,
cultures ions of the product of cluster 222x (Figure 1A) in full-
length (m/zobs = 1,282.6036 [M+2H]
2+), termed astexin-1(23),
and shortened by four amino acids (Ile20-Asn21-Gln22-Asp23)
(m/zobs = 1,047.4944 [M+2H]
2+), termed astexin-1(19), as well
as the first product of cluster 244x (Figure 1A) shortened by
three amino acids (Ser22-Ala23-Asp24) (m/zobs = 1,114.5901
[M+2H]2+), termed astexin-2(21), were detected (data not
shown). As only a low production was observed, a heterologous
expression approach was necessary.
Cloning and Expression of the Astexin-1 Lasso Peptide
Biosynthesis Cluster
The cluster astex_2228-2230ABC (atxABC) (Figure 1A) was
cloned into the pET41a expression vector carrying the T7 pro-
moter, introduced into Escherichia coli BL21 (DE3) by transfor-
mation, and the resulting strain was fermented in M9 minimal
medium at various temperatures and incubation times. After
methanol extraction of both pellet and supernatant, HPLC-MS
analysis revealed masses matching to the predicted masses
of 23 amino acid full-length peptide astexin-1(23) and truncated
derivatives missing 1 to 5 amino acids, termed astexin-1(22) to
astexin-1(18) (Figure 1B). The relative amounts of full-length and
truncated variants did not significantly vary upon different
fermentation times and temperatures, whereas the total peptide
production was best at 37C overnight. Comparison of UV
signal intensities of the three main products, astexin-1(23),
(20), and (19), in pellet and supernatant extracts revealed that
the amounts in the pellet exceed the amounts in the superna-
tant by approximately an order of magnitude, which is an inter-
esting finding, as in the recent publication (Maksimov et al.,
2012) only trace amounts of the products were found in the
pellet.
Furthermore, the D5 truncated variant astexin-1(18) is of
particular interest, as this compound lacks the amino acid560 Chemistry & Biology 20, 558–569, April 18, 2013 ª2013 ElsevierArg19, which was proposed in the recently published structure
(Maksimov et al., 2012) to act as the plug.
Thermal and Proteolytic Stability of Astexin-1
So far, most lasso peptides have been considered to be highly
stable against thermal or chemical denaturation and proteolytic
digestion because of their inimitable three-dimensional fold.
However, only the lasso peptides microcin J25 and capistruin
and the caulosegnins have been investigated for thermal stability
(Hegemann et al., 2013; Knappe et al., 2009; Salomo´n and
Farı´as, 1992). Although all lasso peptides are stable at room
temperature, microcin J25, capistruin, and caulosegnin II can
also withstand prolonged exposure to 95C, whereas cauloseg-
nins I and III were susceptible to thermal unfolding at high
temperatures and are therefore considered thermolabile lasso
peptides. This finding encouraged us to study the thermostability
of astexin-1. When astexin-1(23) was subjected to 95C for 1, 2,
4, and 8 hr and analyzed via HPLC-MS, a second peak with the
same mass and a significantly different retention time was
detectable (Figure 2C). This conversion was irreversible, indi-
cating that it likely represents an unfolding process. Because
of the fast conversion, which was almost completed after 1 hr,
the peptide was also subjected to lower temperature treatments
(20C, 35C, 50C, 65C, and 80C) for 4 hr (Figure 2D). Under
these conditions, the peptide started unfolding at 50C. The
same overall behavior was also observed for the 19 amino acid
(aa) variant astexin-1(19) (Figures 2A and 2B), which lead us to
infer that the terminal 4 aa have only little influence on the general
heat stability. Interestingly, in the range from 50C to 65C, a
third peak with the same mass could be observed for astexin-
1(23), which may be an intermediate of the unfolding process
(Figures 2C and 2D).
Both astexin-1(23) and astexin-1(19) and their unfolded vari-
ants were analyzed by tandem mass spectrometry, revealing a
very similar fragmentation pattern (Figures 2E–2H). Only minor
differences occur in the intensity of certain ions when comparing
the spectra of the respective lasso peptides with their branched
cyclic analogs. The most prominent ions for the lasso peptides
always correspond to the loss of small neutral molecules like
water or ammonia, whereas the unfolded variants have smaller
fragments as the dominating peaks in the spectra. No binary
peptide fragments could be identified due to the low energy of
the used fragmentation method (see Experimental Procedures).
A MALDI-TOF tandem mass experiment reproducing the condi-
tions used in the recent publication (Maksimov et al., 2012)
revealed the presence of mass signals proposed as binary pep-
tide fragments. However, the samemass signals were found in a
thermally unfolded sample of astexin-1(23) (Figure 2I), where the
occurrence of binary peptide fragments is impossible.
The thermal instability of astexin-1may also explain why in this
recent publication (Maksimov et al., 2012) only trace amounts of
astexin-1 were detected in the pellet as the extraction method
used in this publication involved boiling the cells.
The lasso peptides lariatin and caulosegnins I–III have also
been explored toward their stability against carboxypeptidases
(Hegemann et al., 2013; Iwatsuki et al., 2006). These enzymes
generally digest amino acids from the C terminus of an unfolded
protein or peptide. While the lasso fold protects part of the ex-
tracyclic tail, an unfolded, branched cyclic lasso peptideLtd All rights reserved
Figure 2. Heat Stability of the Two Major Compounds Astexin-1(19) and (23), Shown as HPLC Chromatograms and Detailed Fragmentation
Spectra
(A and B) Astexin-1(19) at (A) 95C and (B) after heat treatment at lower temperatures. 1 astexin-1(19) lasso, 2 compound with the samem/z ratio as astexin-1(19),
carboxypeptidase Y digest proves this to be the unfolded variant.
(C and D) Astexin-1(23) at (C) 95C and (D) after heat treatment at lower temperatures. 3 astexin-1(23) lasso, 4 compoundwith the samem/z ratio as astexin-1(23),
may be an unfolding intermediate, 5 compound with the same m/z ratio as astexin-1(23), carboxypeptidase Y digest proves this to be the unfolded variant.
(E–H) Fragmentation spectra of (E) astexin-1(19) lasso (compound 1) and (F) astexin-1(19) unfolded (compound 2). Fragmentation spectra of (G) astexin-1(23)
lasso (compound 3) and (H) astexin-1(23) unfolded (compound 5).
(I) MALDI-TOF spectra of astexin-1(23) in a the lasso fold and b unfolded shown in the same regions as those used by Maksimov et al. (2012). Formerly proposed
binary peptide fragments are marked with colored asterisks.
Additional information on the thermal stability of the astexin-1 variants, including MS and MS2 spectra, is presented in Figure S2.
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Figure 3. Carboxypeptidase Y Treatment of Native Astexin-1(19) and (23) and the Astexin-1(19) F15W Variant, Shown as HPLC
Chromatograms
(A and B) Astexin-1(19) (A) before and (B) after heat treatment. 1 astexin-1(19) lasso, 2 astexin-1(19) unfolded, 3 astexin-1(18) lasso, 4 astexin-1(12) and (13), 5
astexin-1(11), and 6 astexin-1(10).
(C and D) Astexin-1(23) (C) before and (D) after heat treatment. 1 astexin-1(19) lasso, 4 astexin-1(12) and (13), 5 astexin-1(11), 7 astexin-1(23) lasso, 8 astexin-1(21)
lasso, 9 astexin-1(20) lasso, 10 astexin-1(23) unfolded, and 11 unidentified.
(E and F) Astexin-1(19) F15W variant before (E) and after (F) heat treatment. 12 astexin-1(19) F15W lasso.
Additional information about astexin-1 stability against trypsin and of the variants stability against carboxypeptidase Y is presented in Figure S3.
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carboxypeptidase is therefore a useful tool to distinguish
between folded and unfolded state.
Carboxypeptidase Y was only able to very slowly cleave off
one amino acid of astexin-1(19) in its lasso fold; however,
when heat treated, the enzyme rapidly degraded the unfolded
molecule (Figures 3A and 3B). As expected, the heat-unfolded
full-length astexin-1(23) was found to be amenable to carboxy-
peptidase Y (Figure 3D), but surprisingly the untreated molecule
was also found to be carboxypeptidase sensitive, although at a
much slower rate, generating variants with 21, 20, and 19
residues (Figure 3C). Starting from astexin-1(23), no further
degradation products shorter than astexin-1(19) were detected,
indicating that the four C-terminal residues (INQD) of full-length
astexin-1(23) are easily accessible to carboxypeptidase Y,
whereas Arg19 seems to be more shielded but is also acces-
sible according to the proteolytic behavior of astexin-1(19).
This also shows why the D4 variant astexin-1(19) is one of the
major fermentation products that build a stable lasso fold,
although a shorter variant astexin-1(18) could be detected
(Figure 1B).562 Chemistry & Biology 20, 558–569, April 18, 2013 ª2013 ElsevierTo further access the role of Arg19, which is the last residue in
astexin-1(19), trypsin digestion was performed. If Arg19, which is
the only recognized residue for this protease in astexin-1, is truly
the plug amino acid, it should be shielded by the ring and would
not be accessible for degradation. Both lasso and unfolded
astexin-1(23) were degraded by trypsin to the D4 variant
astexin-1(19), with the unfolded variant being degraded slightly
faster (Figures S3C and S3D available online). This finding is in
accordance with the carboxypeptidase Y treatment and further-
more reveals the accessibility of the arginine residue at position
19, which was already suggested by the carboxypeptidase
digestion of astexin-1(19).
Mutational Analysis of the Precursor Peptide
Several mutational studies of microcin J25, capistruin, and the
recently discovered caulosegnins have shown that these are
useful approaches to gain insights into the specificity of the
biosynthetic machinery or to gain information about the mode
of action of a lasso peptide (Cheung et al., 2010; Hegemann
et al., 2013; Knappe et al., 2009; Pan and Link 2011; Pan et al.,
2012b; Pavlova et al., 2008; Semenova et al., 2005). Therefore,Ltd All rights reserved
Figure 4. Production of Astexin-1 Variants Compared to Native Astexin-1 Production Level, Shown in a Color-Coded Schematic Represen-
tation
Values are average of three independent measurements; error bars show standard deviation. +, detected byMS;, not detected byMS. A summary of the results
of the mutational analysis, including the stability of all variants, is presented in Table S1.
See also Table S6.
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specificity of the processing enzymes and to identify the location
of important residues in the tail region. Finally, rational mutagen-
esis was applied to improve the thermal stability of this lasso
peptide.
To gain knowledge about the tolerance of the maturation
machinery of astexin-1, variants of the threonine, which is
conserved in all known lasso peptide precursors, and the argi-
nine in front of the cleavage site (T-2A, T-2V, T-2S, R-1A) were
constructed. Furthermore the amino acids, which are involved
in the macrolactam ring formation, were altered yielding variants
G1C and D9E (Figure 4). The results obtained for the mutagen-
esis of the conserved Thr-2 were in contrast to the previously
published observations for microcin J25, capistruin, and the
caulosegnins (Hegemann et al., 2013; Pan et al., 2012b). From
the three variants analyzed in this study, two were only detected
in trace amounts (T-2A and T-2S), whereas the third exchange
(T-2V) completely abolished astexin-1 production (Figure 4).
This indicates that the astexin-1 maturation machinery is less
tolerant for substitutions of this conserved threonine than the
processing enzymes of capistruin, microcinJ25, and the caulo-
segnins. Although substitution of the Arg-1 (R-1A) had a lessChemistry & Biology 20,serious impact on peptide production, the detected amount of
this variant was only 20% compared to the native system (Fig-
ure 4). Although this is in accordance with the qualitative muta-
tional study of capistruin (Knappe et al., 2009), in which the
His-1 could be exchanged for alanine, it indicates that this
location seems to be not essential but influential for efficient
recognition by the processing enzymes. Additionally, there is
some general conservation of a positively charged residue
(His, Lys, Arg) at this position in putative precursor peptides in
proteobacteria, recently identified by genomemining (Maksimov
et al., 2012; Severinov et al., 2007).
Mutation of the macrolactam ring-forming amino acids (Gly1
and Asp9) for microcin J25 was addressed by Pavlova et al.
(2008) and for capistruin by Knappe et al. (2009), which in both
cases revealed no tolerance for substitutions. For astexin-1 a
similar result is presented here for Gly1, where an exchange to
cysteine abolished production; however, a substitution of Asp9
by glutamic acid (D9E) generates a variant detectable by MS.
The retention time, which should not significantly be altered by
such a conserved mutation (Asp to Glu), was 3 min higher
compared to the native peptide, and upon heat treatment
of the extract, no change in retention time was observed558–569, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 563
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lytic stability was elucidated by treating the dried pellet extract of
a fermentation of this variant with carboxypeptidase Y. The
following HPLC-MS analysis revealed the instability of the D9E
variant, indicating that it very likely does not adopt a lasso fold
(Figure S3K), which could also explain the detected low
amounts. In context of the low thermal stability of native as-
texin-1, it is not surprising that through the expansion of the
macrolactam ring size by one carbon atom (Asp9 to Glu9) in
this variant, the lasso fold cannot be maintained anymore.
To elucidate the tolerance of substitutions for potential scaf-
fold applications as well as the identification of important
residues for the biosynthesis, single-residue alanine substitu-
tions were constructed for all of the 14 residues of the extracyclic
part of astexin-1 (Figure 4; Table S1). The overall tolerance
against these substitutions was rather high, with exception of
the Y14A and F15A variants, which could hardly or not at all be
detected by HPLC-MS, respectively. Interestingly, most of the
mutations altering the chemical and/or sterical nature of the
amino acid (such as G11A, Q12A, T13A, E16A, E17A, S18A,
R19A, N21A, Q22A, and D23A) had only little to moderate effects
on astexin-1 production (Figure 4; Table S1).
In order to understand the importance of the residues Tyr14
and Phe15 and to explain the surprisingly well produced variant
R19A (Figure 4; Table S1), combined tandem mass spectro-
metric analysis, thermal stability investigation, and carboxypep-
tidase digestion of several mutants were performed. According
to its thermal and proteolytic behavior, the Y14A variant was
found to be most likely already unfolded (Figures S2B and
S3L), whereas the R19A variant adopted the lasso fold and
was as heat labile as native astexin-1 (comparable results shown
in Figure S2A), which strongly contradicts its formerly proposed
role as the plug amino acid. To investigate the importance of the
long tail and to identify potentially important residues, truncation
mutants were generated and analyzed revealing that truncated
variants from astexin-1(22) (D1) to astexin-1(15) (D8) could be de-
tected by MS (Figure 4). Furthermore, the variants astexin-1(22)
(D1) to astexin-1(16) (D7) could be investigated for thermal stabil-
ity and astexin-1(17) to astexin-1(16) also for proteolytic stability
with HPLC-MS and tandem mass spectrometry techniques.
These studies revealed that all truncation variants (D1 to D7)
are heat-labile lasso peptides as native astexin-1 (Figures S2A
and S3E–S3H). Together these observations, in particular the
low tolerance for substitution of Tyr14 and Phe15, the behavior
of the Y14A variant, and the possibility of creating heavily trun-
cated variants that behave almost like native astexin-1(23),
strongly suggest that Tyr14 and Phe15 play a key role in stabiliz-
ing the lasso structure and additionally exclude Arg19 from being
the only residue involved in maintenance of the lasso fold.
Because the native astexin-1 is quite heat labile, the question
arose, whether it is possible to create a thermostable variant of
this peptide. Therefore, three variants were generated by replac-
ing the three largest residues in the tail (Tyr14, Phe15, and Arg19)
with tryptophan. HPLC-MS analysis, tandem mass spectrom-
etry, and carboxypeptidase Y digestion before and after heat
treatment clearly show that F15W is a heat-stable variant of as-
texin-1 (Figures 3E and 3F; Figure S2C), whereas the other two
variants Y14W and R19W behave like native astexin-1 under
thermally denaturing conditions (Figures S3I and S3J). This con-564 Chemistry & Biology 20, 558–569, April 18, 2013 ª2013 Elsevierfirms the assumption that Phe15 is the essential, bulky residue
involved in the entrapment of the C-terminal tail and mainte-
nance of the lasso fold.
Structure Elucidation Using NMR Spectroscopy
The gene cluster as well as an NMR 3D structure of astexin-1(23)
was presented as a proof-of-principle example to the ‘‘sequence
pattern matching’’ approach for the genome mining of lasso
peptides developed by Maksimov et al. (2012). The structure
(Protein Data Bank [PDB] ID code 2LTI) was determined in
DMSO-d6 at 295 K with the following spectroscopic and struc-
tural features: (1) astexin-1(23) possessed a lasso structure, (2)
the isopeptide bond forming the macrolactam ring was between
Gly1 and Asp9, (3) an eight-residue loop above and a six-residue
tail under the macrolactam ring was defined, with Glu17 above,
Ser18 passing, and Arg19 under the ring, (4) abnormal hydrogen
bond interactions between the loop (above the ring) and the tail
(under the ring) were identified (in Figure 6C of their article) to sta-
bilize the lasso structure, and (5) a very small 1H chemical shift
dispersion for the amide protons (0.7 ppm) and the aH protons
(1.0 ppm). The results of our rather extended mutational and
stability studies on astexin-1(23) and astexin-1(19) are in accor-
dance with features (1) and (2) but in discrepancy with feature (3).
Features (4) and (5) are uncommon to most of the known NMR
structures of lasso peptides (Xie and Marahiel, 2012).
These conflicting results and the fact that both astexin-1(19)
and astexin-1(23) are highly hydrophilic prompted us to investi-
gate the 3D structures of these peptides in aqueous solution
thoroughly by using one- (1D) and two-dimensional (2D) NMR
spectra. Thus, NMR spectra were recorded on sample 1:
3.5 mg of astexin-1(23) dissolved in 250 ml of H2O/D2O (9:1)
and sample 2: 3.0 mg of astexin-1(19) dissolved in 250 ml of
H2O/D2O (9:1). The samples were prepared in standard way
and filled into 3 mm NMR tubes (see the Experimental Proce-
dures for NMR experimental details). The concentrations of the
samples were 5.5 and 5.7 mM, respectively. The 1H spectra of
sample 1 at temperatures between 278 and 298 Kwith 5 K incre-
ments are shown in Figure 5. Spectra are presented in the region
9.65–6.75 ppm for clarity, and labels for the signal assignments
of the amide protons are attached. Neat and well-resolved single
set of signals were observed, as reflected in Figure 5. A diverse
distribution of the temperature response of these signals re-
vealed a stable lasso folding of this peptide (Xie and Marahiel,
2012). The best signal resolution was observed at 288 K, and a
full signal assignment (Table S2) was thus fulfilled by standard
procedure (see below) at this temperature.
In a similar way, variable temperature 1H spectra of sample 2
at the same temperatures were recorded (see Figure S4 for
spectra). Close inspection on each pair of spectra at the same
temperature revealed that the spectra of sample 2 appear to
be those of sample 1 subtracted with signals of the last four
residues of sample 1, i.e., I20N21Q22D23. On the basis of the
close similarity in variable temperature 1H spectra of samples 1
and 2, we concluded that the two peptides under the same con-
ditions possess 3D structures with close similarity. Thus, the last
four residues in the C-terminal tail of astexin-1(23) have little
contribution to the core of its 3D structure under the applied
experimental condition. Therefore, detailed structural determi-
nation was performed on astexin-1(19).Ltd All rights reserved
Figure 5. Variable Temperature 1H Spectra
in the Region 9.65–6.75 ppm of Astexin-
1(23) in H2O/D2O at a Ratio of 9:1
The labels are the signal assignments of the
amide protons. For comparison, the 1H spectra at
variable temperatures for astexin-1(19) are shown
in Figure S4.
See also Tables S2 and S3.
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procedures (Wu¨thrich, 1986). A combination of DQF-COSY and
nuclear Overhauser effect spectroscopy (NOESY) produced
sequential assignments (i.e., all aH and NH and their sequence
in the backbone), and a combination of DQF-COSY and TOCSY
allowed the determination of the side chains. One pure confor-
mation was observed. Full assignment of 1H signals was thus
obtained (NOESY spectrum: Figure S5; 1H chemical shifts:
Table S3). Strong NOE contacts between the NH of Gly1 and
the bH of Asp9, showing an internal linkage between the two
residues, were observed. Strong sequential aH–dH NOESY
cross-peaks were detected, which showed the transconforma-
tion of Pro8. Inspection of 1H spectra between 278 and 298 K
(Figure S4) revealed almost no temperature dependence of
the NH Asp9 and very weak dependence of those of Tyr14
and Phe15. Variable delay 1H spectra in D2O (data not shown)
are consistent with a very slow deuterium exchange of the
amide protons of these residues. Furthermore, a large number
of long-range NOE contacts were observed. These are the
dNN(i,j) connectivity between Ser3–Tyr14 and Glu7–Phe15,
the daN(i,j) connectivity between Pro8–Phe15 and Tyr14–Asp9,
the dbN(i,j) connectivity between Asp9–Gly1, Tyr14–Gly6,
and Tyr14–Val6, and the daa(i,j) connectivity between Gly1–
Phe15 and Pro8–Tyr14. All these short distances revealed in
the NOESY spectrum are in favor of the lasso structure of
astexin-1(19).
Structure calculations were performed with the program
CYANA (v. 2.1) (Herrmann et al., 2002). The internal linkage
was realized by setting the distance constraints between N of
Gly1 and Cg of Asp9 to be 1.33 A˚. NOE cross-peaks observed
in the of 100 ms mixing time NOESY experiment were converted
into distance constraints manually. In this way, 169 unambigu-
ous distance constraints were obtained, 56 for the backbone,
24 for long-range interactions, and 89 for the side chains.
Thus, there was an average of 8.9 distance constraints per res-
idue. In addition, constraints of torsion angles f and c1 wereChemistry & Biology 20, 558–569, April 18, 2013determined by analyzing the vicinal
coupling constants 3JHNa and
3Jab.
The above-mentioned constraints
were used in the simulated annealing pro-
tocol for calculation in the CYANA (v. 2.1)
program. The calculation initiated with 50
random conformers, and the resultant
structures were engineered by the pro-
gram package Sybyl (v. 7.3) (Tripos,
2006) to include the covalent linkage
between the nitrogen of Gly1 and Cg of
Asp9, followed by energy minimization
under NMR constraints using a TRIPOSforce field within Sybyl. Thus, on the basis of low energies and
minimal violations of the experimental data, a family of 20 struc-
tures was chosen. These 20 energy-minimized conformers show
an average root-mean-square deviation (rmsd) of 0.03 A˚ and are
kept to represent the solution structure of astexin-1(19) (Figure 6;
PDB ID code 2M37).
The family of 20 structures shown in Figure 6 represents the
lasso fold of astexin-1(19) in aqueous solution at 10C. On the
basis of the close similarity in the 1H variable temperature
spectra between astexin-1(19) and astexin-1(23), the lasso
structure of 19 amino acids is assumed to represent the core
of the 3D structure of astexin-1(23) in solution under the same
conditions. Thus, our lasso structure shares the feature of the
lasso ring being a nine-membered ring with that of astexin-
1(23) defined by Maksimov et al. (2012). Furthermore, our struc-
ture shows the following properties, which are in discrepancy
with the structure defined by Maksimov et al. (2012): (3) a five-
membered loop above and a five-membered tail (for astexin-
1(19)) below the macrolactam ring, whereby Tyr14 and Phe15
are located on opposite sides of the ring and serve as steric
lock; (4) a short fragment of relative weak b sheet could be
defined between E7P8 and Y14F15 on the basis of the observed
long-range NOE contacts (Figure 6C); and (5) no regular turn
could be assigned to the loop. All these structural features are
in accordance with the properties identified in the mutagenesis
and stability studies. Therefore, similar to microcin J25 (Bayro
et al., 2003; Rosengren et al., 2003;Wilson et al., 2003), the steric
lock by bulky residues Tyr14 and Phe15 and the formation of a b
sheet are assumed to be the major factors for the stability of the
lasso fold in astexin-1. One consistent lasso structure was
identified for microcin J25 both in aqueous solution (Bayro
et al., 2003; Rosengren et al., 2003) and in DMSO-d6 (Wilson
et al., 2003). Thus, we concluded that our 3D structure of
astexin-1(19) in aqueous solution represents the correct lasso
folding of the title peptides of astexin-1 and raised the question
of whether the original NMR data of astexin-1(23) in DMSO-d6ª2013 Elsevier Ltd All rights reserved 565
Figure 6. 3D NMR Structure of Astexin-1(19)
(A) Superimposition of the 20 lowest energy structures of astexin-1(19). Structures are superimposed over all backbone atoms. The isopeptide bond forming Asp9
is colored in red; the remaining ring amino acids are colored in yellow; and the tail residues are colored in blue.
(B) Schematic representation of the astexin-1(19) structure.
(C) Scheme of the small b sheet between E7-P8 and Y14-F15.
(D) Representative average structure of astexin-1(19) shown as relaxed eyes stereo picture. Backbone of the tail is colored in blue, and backbone of the ring is
colored in dark gray. Side chains of the upper (Tyr14) and lower (Phe15) plug residues are shown in red, and other side chains are shown in light gray. The structure
is tilted and turned for better visibility of residues. NOESY NMR spectra used for determination of the structure are shown in Figure S5.
See also Figure S7 and Table S4.
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the lasso fold. A quality comparison of the 20 minimum energy
structures and their Ramachandran plots is shown in Figure S6.
Although the entrapment of the ring between the two residues
Tyr14 and Phe15, shown in our NMR structure, appears to confer
a rigid fixation of the tail motion, the heat stability investigation
suggests otherwise. A mapping of the solvent-accessible
surface on the average structure reveals a hole in the ring in a
comparable size to the Phe15 side chain, suggesting a possible
passage, which may explain the observed thermal sensitivity of
the native lasso peptide as well as the thermal stability of the
F15W variant (Figure 7). Even though only the structure of the
truncated variant astexin-1(19) was elucidated, the similarity of
the recorded NMR spectra of both variants was high enough to
assume that full-length astexin-1(23) adopts the same fold.
With a length of nine amino acids, the tail of astexin-1(23) is
therefore the longest tail below the ring of all lasso peptides
known so far.
In conclusion, we successfully obtained two main products
from the recently identified biosynthetic gene cluster of the lasso
peptide astexin-1. Both astexin-1(19) and astexin-1(23) were
shown to be sensitive to thermal unfolding, while exhibiting
certain stability against proteolytic degradation by carboxypep-
tidase Y and trypsin. Mutational analysis of the leader and core
sequence of the precursor peptide provided important insights566 Chemistry & Biology 20, 558–569, April 18, 2013 ª2013 Elsevierinto the specificity of the biosynthetic machinery and revealed
some hot spots that have great influence on in vivo production
and in vitro stability, in the sequence of this lasso peptide. Finally,
we performed a thorough NMR spectroscopic study on astexin-
1(23) and astexin-1(19) and determined the 3D structure of
astexin-1(19) in aqueous solution.
SIGNIFICANCE
Despite the predictability of their gene clusters by a
genome-mining-centered approach, lasso peptides are still
a young class of ribosomally assembled natural products,
with only few known representatives. In this study, we inves-
tigate the structure-stability relationship of the lasso pep-
tide astexin-1, revealing it to be one of the few examples in
its class to be a heat-sensitive molecule. Further investiga-
tion by mutational analysis showed a broad tolerance of
the astexin-1 biosynthetic machinery for most residues
located in the tail region, with some exceptions of hot spots,
whereas mutations at residues involved in the macrolactam
ring formation or around the protease cut site within the
leader sequence drastically influenced the lasso peptide
production in vivo. Astexin-1 is an example of a lasso pep-
tide for which it was possible to exchange the macrolactam
ring-forming acidic residue yielding a branched cyclicLtd All rights reserved
Figure 7. Interactions of the C-Terminal Tail and the Macrocyclic Ring of Astexin-1(19)
(A–C) 3D structure of astexin-1(19), where entire backbone and side chains of the plug amino acids Y14 and F15 are shown as sticks, and complete macrolactam
ring and plug side chains (Y14, F15 on opposite sides of the macrolactam ring) are shown as solvent-accessible surfaces. View (A) from the side, (B) from above,
and (C) from below the ring. Isopeptide bond in each panel is on the left-hand side. Quality comparison of structures and Ramachandran plots of the current and
the recently published structure are shown in Figure S6.
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were further studied regarding their in vitro stability.
However, none of the observed behaviors concerning ther-
mal stability of parental astexin-1 or that of the generated
variants was compatible with the recently published struc-
ture of astexin-1 (Maksimov et al., 2012). This inconsistency
encouraged us to reinvestigate the astexin-1 structure. Our
NMR studies on astexin-1(19) revealed a tight structure with
a short loop region above the nine-membered macrolactam
ring and a long tail comprising of nine residues for the full-
length peptide of which Phe15, and not Arg19 (as published
byMaksimov et al. 2012), acts as the plug residue to trap the
tail. Understanding these molecular aspects of the struc-
ture-stability interactions of astexin-1 allowed the conver-
sion of this heat-labile natural product into a thermostable
one by rational design.
EXPERIMENTAL PROCEDURES
Strains and general methods, such as cloning, construction of mutants, and
heterologous expression, are described in the Supplemental Experimental
Procedures.
Purification of Astexin-1 and Variants
After centrifugation (6,000 rpm), the cell pellet was combined and extracted
with methanol for 1 hr at room temperature (RT). The solvent obtained after
extraction was evaporated to dryness with a rotational evaporator at 30C,
or in case of the variants, it was removed via lyophillization.
Crude extracts of native astexin-1 were resuspended in 20% acetonitrile
and subsequently applied to a preparative RP-HPLC system (1100 series,
Agilent, Santa Clara, CA, USA) using a C18HTec column (250 3 21 mm) with
the following gradient of water/0.1% trifluoroacetic acid (solvent A) and aceto-
nitrile/0.1% trifluoroacetic acid (solvent B) with a flow rate of 18ml/min: a linear
increase from 20%B to 30%B in 30min followed by the washing increasing to
95% B in 2 min and holding 95% B for 5 min. Retention times (Rt) of the
produced compounds were between 8 and 19 min (Figure S1A). Fractions
containing astexin-1(23) and (19) were separately combined, lyophilized, and
subjected to another HPLC purification step.
Further purification of the products was performed with an analytical scale
HPLC system (1260 series, Agilent) with a fraction collector using a Nucleodur
C18ec column (125 3 2 mm) at a column temperature of 50C and a flow rate
of 0.2 ml/min with the following gradient using the same solvents as before:
linear increase from 20% B to 27.5% B in 15 min followed by the washing per-
formed in the same manner as the preparative scale. The truncated productChemistry & Biology 20,astexin-1(19) had an Rt of 8.2 min, and the full-length product astexin-1(23)
had an Rt of 10.3 min (Figure S1B). Fractions were combined and lyophilized,
and in case of astexin-1(23), they were resuspended in 15% acetonitrile and
subjected to a third HPLC purification step.
Final purification of the full-length product was performed with the analytical
scale HPLC system using a polar RP column (Synergi [Phenomenex, Torrance,
CA, USA], 4m 2503 2 mm) at a column temperature of 25C and a flow rate of
0.5 ml/min with the following gradient using the same solvents as before: 17%
B is held for 15 min and then washing is applied in the same manner as before.
The retention time for the full-length product was 6.4min (Figure S1C). The final
yield of astexin-1(23) was approximately 4 mg/l culture, and that of astexin-
1(19) was about 5 mg/l.
Variants were purified with the preparative HPLC system. For variants D6 aa
and F15W, the same gradient as for the native astexin-1 was used. Variants D7
aa and R19Wwere purified using a gradient going from 25% to 35% solvent B
in 30 min, whereas all other steps were performed as mentioned before.
Mass Spectrometric Analysis
Mass spectrometric analysis of astexin-1 and variant extracts were performed
with a LTQ-FT ultrainstrument (Thermo Fisher Scientific, Waltham, MA, USA)
connected to a micropore 1100 HPLC system (Agilent) using sample amounts
of up to 100 ml. For detection, the UV absorption at 215 nm was recorded.
Separation was achieved using a CC Nucleosil 300-8 C18 column (125 3
2 mm) (Macherey-Nagel, Dueren, Germany), applying the following gradient
of water/0.1% trifluoroacetic acid (solvent A) and acetonitrile/0.1% trifluoro-
acetic acid (solvent B) at a column temperature of 40C and a flow rate of
0.2 ml/min: starting with a linear increase from 5% to 50% B in 30 min, a sub-
sequent increase from 50% to 95% B in 2 min, and holding 95% B for addi-
tional 5 min.
For product quantification, UV peak areas were integrated and relative pro-
duction was determined by comparison to the UV peak area of the corre-
sponding wild-type.
Collision-induceddissociation fragmentation studieswithin the linear ion trap
weredoneusingonlineHPLC-MS. Inmost cases, thedoubly charged ionswere
selected for fragmentation, as they were the dominant species in the spectra,
while for shorter variants also the singly charged species could be analyzed.
The energy for fragmentation was set to 35 for every measurement performed.
Mass spectrometric analysis after the thermal stability and protease assays
of the purified lasso peptides and variants thereof was performed with a 1100
series MSD (Hewlett-Packard) coupled with a micropore 1260 HPLC system
(Agilent).
For astexin-1(19) and astexin-1(23) and variants D6 and F15W, the HPLC-
MS runs were performed with the same gradient as in the second purification
step of astexin-1. An adapted gradient was used for variant D7, going from
22.5% B to 30% B in 15 min. For variant R19W, the gradient was further
adjusted, starting from 25% B and finishing with 32.5% B. The washing steps
were applied analog to the purification.558–569, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 567
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(AB SCIEX, Framingham, MA, USA). Samples of folded and thermally unfolded
astexin-1(23) weremixedwith dihydroxybenzoic acid as thematrix on aMALDI
target, dried for 15 min, and applied to the spectrometer.
Heat Stability Assays of Astexin-1 and Variants
To investigate the thermal stability of the main lasso peptide products astexin-
1(23) and astexin-1(19), a solution of 10 mg purified lasso peptide was incu-
bated at 95C for either 1, 2, 4, or 8 hr or for 4 hr at either 20Ca, 35C,
50C, 65C, 80C, or 95C. Samples were cooled to 4C and were subse-
quently analyzed via HPLC-MS using the same gradient as in the second
purification step of astexin-1.
Heat stability of the variants was investigated by incubating 25 ml of the
respective extract at 95C for 1 hr. The samples were cooled and analyzed
via HPLC-MS. As reference, 25 ml of the respective untreated extract were
analyzed.
Protease Assays of Astexin-1 and Variants
Stability against proteolytic degradation of the lasso peptides and the
branched cyclic variants were investigated by incubating 10 mg of the purified
lasso peptide before and after heat treatment (95C, 1 hr) with different
proteases.
The carboxypeptidase Y assays were performed with 0.5 U carboxypepti-
dase Y in a buffer containing 50 mM MES and 1 mM CaCl2 at a pH of 6.75
for 4 hr or 16 hr at 25C. For variants that were not isolated because of low
production, 25 ml of the pellet extract were evaporated to dryness at a con-
centrator (model 5301, Eppendorf, Hamberg, Germany), resuspended in a
carboxypeptidase Y (1.0 U) containing buffer (50 mM MES and 1 mM CaCl2
[pH 6.75]), and incubated for 2 hr at 25C. The trypsin assays were performed
with 0.5 mg trypsin in a buffer containing 50 mM Tris-HCl and 1 mM CaCl2 at a
pH of 7.6 for 4 hr at 25C.
Distinction between Lasso Peptide and Branched-Cyclic Peptide
If not further stated in the paper, the two topologies of a peptide were distin-
guished by the difference in their retention time and their fragmentation
patterns before and after heat treatment as well as their stability against diges-
tion by carboxypeptidase Y. Heat treatment of the two lasso peptide main
products and almost all variants generated showed a second peak after
HPLC separation with a significantly higher retention time. This second
peak, in contrast to the first one, is sensitive to carboxypeptidase Y digestion
and can therefore be classified as a branched cyclic peptide, whereas the first
compound, which has the lasso fold, could only be digested to a certain extent
or not at all depending on the length of the tail. Furthermore, both topologies
have distinguishable fragmentation patterns in tandem mass spectrometry.
Although no binary peptide fragments have been observed, the general frag-
mentation of a lasso peptide is weaker than that of a branched cyclic peptide.
In general, the lasso peptides show larger fragments, and the most intensive
peak corresponds to the loss of neutral molecules like H2O and NH3.
NMR Spectroscopy
Three samples were used for the NMR spectroscopic studies. Sample 1 con-
tained 3.5 mg of astexin-1(23) in 250 ml H2O/D2O (9:1), and sample 2 contained
3.0 mg of astexin-1(19) in 250 ml H2O/D2O (9:1), whereas sample 3was 3.0 mg
of astexin-1(19) in 250 ml D2O. Samples were filled in Wilmad 3 mm tubes
(Rototec Spintec, Griesheim, Germany). All the peptides studied were at
natural abundance. Spectra were recorded on a Bruker Avance 600 MHz
spectrometer equipped with an inverse triple-resonance 1H-13C-15N probe
with z-gradient. Temperature influence on samples 1 and 2 was studied by
recording 1H spectra at temperatures between 278 and 298 K with a 5 K incre-
ment. The 2D experiments DQF-COSY (Rance et al., 1983), TOCSY (Bax and
Davis, 1985), and NOESY (Jeener et al., 1979) were performed in the standard
way, with water suppression using excitation sculpting method (Hwang and
Shaka, 1995) on samples 1 and 2 for sequential assignments. For sample 1,
the sequential assignment was done at 288 K. Because of crowdedness and
partial overlap of the signals, further 2D spectra recorded at 283 K were
used to assist the assignment. Sample 2 has a smaller size, thus its sequential
assignment was easily fulfilled at 283 K. The TOCSY spectra were recorded at
an 80 ms mixing time, and NOESY spectra were recorded at 100 and 300 ms
mixing times. 1D spectra were acquired with 65,536 data points, whereas 2D568 Chemistry & Biology 20, 558–569, April 18, 2013 ª2013 Elsevierspectra were collected using 4,096 points in the F2 dimension and 512 incre-
ments in the F1 dimension. Both 1D and 2D spectra were recorded with 32
transients and a relaxation delay of 3.0 s. Chemical shifts were referenced to
H2O signal, which in turn was calibrated using 2,2-dimethyl-2-silapentane-5-
sulfonate (DSS) as internal standard in a different sample at the same temper-
ature. To study the proton/deuterium exchange, 1H and TOCSY spectra were
recorded on sample 3 at 283 K sequentially 1 hr, 1 day, 7 days, and 28 days
after sample preparation. All spectra were processed with Bruker TOPSPIN
(v. 3.1). NOE cross-peaks were analyzed within the program Sparky (Goddard
and Kneller, 2007).
Structure Calculations
Structure calculation was performed on astexin-1(19) in H2O/D2O (9:1) at 283
K. NOESY cross-peaks with mixing time 100 ms were used to create dis-
tance constraints. Constraints of torsion angle f were determined by
analyzing the vicinal coupling constants 3JHNa, whereas those of c
1 were
determined by fulfilling stereospecific assignment on the basis of NOE con-
tacts and 3Jab (Wagner, 1990). These constraints were used in the simulated
annealing protocol, and the structure calculations were done with the pro-
gram CYANA 2.1 (Herrmann et al., 2002). The coordinates of the 20 lowest
energy structures to present the solution structure of astexin-1(19) have
been submitted to the Protein Data Bank (PDB) and assigned the accession
number 2M37.
ACCESSION NUMBERS
The Protein Data Bank accession number for the coordinates of the 20 lowest
energy structures to present the solution structure of astexin-1(19) is 2M37.
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